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ss: petaSevoﬂurane Relieves Lung Function Deterioration
After Cardiopulmonary Bypass
Adam L. Balogh, MDn,†, Ferenc Peták, PhD†,1,
Gergely H. Fodor, MD, PhD†, Roberta Sudy, MDn,†,
Barna Babik, MD, PhDn
nDepartment of Anesthesiology and Intensive Therapy, University of Szeged, Szeged, Hungary
†Department of Medical Physics and Informatics, University of Szeged, Szeged, HungaryObjective: To investigate sevoﬂurane’s potential to alleviate the detrimental pulmonary changes after cardiopulmonary bypass (CPB).
Design: Prospective, randomized clinical investigation.
Setting: University hospital.
Participants: One hundred ninety patients undergoing elective cardiac surgery.
Interventions: Ninety-nine patients under intravenous anesthesia were administered 1 minimal alveolar concentration of sevoﬂurane for
5 minutes after being weaned from CPB (group SEV); intravenous anesthesia was maintained in the other 91 patients (group CTRL).
Measurements and Main Results: Measurements were performed with open chest: before CPB, after CPB, and after intervention. The lungs’
mechanical impedance and capnogram traces were recorded, arterial and central venous blood samples were analyzed, and lung compliance was
documented. Airway resistance, tissue damping, and elastance were obtained from the impedance spectra. The capnogram phase III slope was
determined using linear regression. The partial pressure of oxygen in the arterial blood/fraction of inspired oxygen ratio and shunt fraction were
calculated from blood gas parameters. After CPB, sevoﬂurane induced bronchodilation, reﬂected in marked drops in airway resistance
and smaller improvements in lung tissue viscoelasticity indicated by decreases in tissue damping and elastance. These changes were reﬂected
in a decreased capnogram phase III slope and shunt fraction and increased partial pressure of oxygen in the arterial blood/fraction of inspired
oxygen ratio and lung compliance. The more severe deteriorations that occurred after CPB, the greater improvements by sevoﬂurane were
observed.
Conclusions: Sevoﬂurane can alleviate CPB-induced bronchoconstriction, compromised lung tissue mechanics, and enhanced intrapulmonary
shunt. This beneﬁt has particular importance in patients with severe CPB-induced lung function deterioration.
& 2017 Elsevier Inc. All rights reserved.
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Airway dilation by volatile agents also has been conﬁrmed after
endogenous release of constrictor mediators in clinical investi-
gations; elevations in the airway tone in these previous clinical
studies were induced by administering thiopental and succinyl-
choline and/or performing endotracheal intubation.4,5
Another relevant trigger of perioperative bronchoconstric-
tion is cardiopulmonary bypass (CPB) applied during cardiac
surgery.6,7 The use of this technique induces well-described
multimodal detrimental changes in the lungs.8 The systemic
A.L. Balogh et al. / Journal of Cardiothoracic and Vascular Anesthesia 31 (2017) 2017–20262018inﬂammatory response is initiated by contact activation,
ischemia-reperfusion, and endotoxemia, which are followed
by the activation of complement, cytokine, and coagulation/
ﬁbrinolysis cascades9–11 which, in turn, result in leukocyte
activation.12 Free oxygen radicals, platelet-activating factor,
and leukotrienes increase vascular permeability and inter-
stitial edema.13 Furthermore, mast cells and basophils
release bronchoactive mediators, such as histamine and
serotonin.14,15 The subsequent overall pulmonary dysfunc-
tion can be manifested in important clinical pathologies,
such as airway constriction, atelectasis, hypoxemia, elevated
right heart afterload, and reduced systemic venous return.
Sevoﬂurane is among the most commonly used volatile
anesthetics, with beneﬁcial pharmacokinetic properties, and
advantageous bronchial effects compared with other volatile
anesthetics.4 The effects of sevoﬂurane on lung function have
been investigated extensively in humans and animal models.
However, in these studies simple bronchial challenges were
applied, mainly inducing speciﬁc bronchoconstriction of
cholinergic or histaminergic origin.1,16,17 Even though the
beneﬁcial pulmonary proﬁle of sevoﬂurane after CPB can
be anticipated, the only previous study to investigate its effects
on the lungs after this complex challenge was limited to
demonstrating beneﬁcial changes in leukocyte counts and
interleukin levels.18 Furthermore, the effects of sevoﬂurane
on lung functional changes, particularly increased interstitial
edema and ventilation heterogeneity after CPB, have not
been investigated. The authors therefore aimed to characterize
the therapeutic potential of this volatile agent against
adverse pulmonary changes induced by CPB by assessing
airway and lung tissue mechanics, ventilation heterogeneity,
ventilation-perfusion mismatch, and gas exchange. The authors
hypothesized that after deleterious lung function changes
from CPB, the expected bronchodilation by sevoﬂurane is
associated with improvements in lung tissue viscoelasticity
and diminished ventilation heterogeneities, which may enhance
oxygenation.Methods
Patients
The protocol was approved by the Human Research
Ethics Committee, University of Szeged, Hungary (No.
WHO 2788). Patients undergoing elective cardiac surgery
were enrolled in the study between September 2014 and
November 2015; the process is shown in Figure 1. Inclusion
criteria were an ejection fraction 430%, a body mass index
o35 kg/m2, and a lack of endocarditis. Written, informed
consent was obtained from the patients participating in the
study, who then were assigned randomly to the sevoﬂurane
group (SEV) or the control group (CTRL). Measurement data
of 190 participants (SEV [n ¼ 99], CTRL [n ¼ 91]; 107
males, 83 females, 63 y of age [range 32-85 y]) were included
in the analysis. Table 1 summarizes the demographic, anthro-
pometric, and clinical characteristics of the patients.Anesthesia and Surgery
The patients were premedicated with intramuscular mor-
phine (0.07 mg/kg) and midazolam (0.07 mg/kg) 1 hour before
the surgery. Anesthesia was induced with intravenous (IV)
midazolam (30 μg/kg), sufentanil (0.4-0.5 μg/kg), and propo-
fol (0.3-0.5 mg/kg) and was maintained with an IV infusion
of propofol (50 mg/kg/min). Neuromuscular blockade was
achieved with IV boluses of rocuronium (0.6 mg/kg for
induction and 0.2 mg/kg every 30 minutes for maintenance).
A cuffed tracheal tube with an internal diameter of 7, 8, or
9 mm was used for tracheal intubation, and patients were
ventilated with a Dräger Zeus anesthesia machine (Dräger,
Lübeck, Germany) in volume-controlled mode with descend-
ing ﬂow. Ventilation frequency was set to 12-to-14 breaths/
minute, and a tidal volume of 7 mL/kg and a positive end-
expiratory pressure of 4 cmH2O were applied. Mechanical
ventilation was initiated with a fraction of inspired oxygen
(FIO2) of 0.5 that was set to 0.8 after CPB.
Before CPB, the membrane oxygenator was primed with
1,500 mL of lactated Ringer’s solution. Heparin was adminis-
tered at a dose of 300 U/kg, with the anticoagulation time
maintained at 300 seconds. Moderate hypothermia was
induced routinely (esophageal temperature of 321C). During
CPB, mechanical ventilation was stopped, and the ventilator
was disconnected without applying positive airway pressure.
Before restoring ventilation, the lungs were inﬂated 3-to-
5 times to a peak airway pressure of 30 cmH2O to facilitate
lung recruitment.
Forced Oscillatory Measurements
Changes in the airway and tissue mechanical properties
from CPB and sevoﬂurane were assessed by measuring the
low-frequency forced oscillatory input impedance of the lungs,
as detailed previously.6 Brieﬂy, a T-piece with 2 collapsible
segments was attached to the distal tracheal tube, with one end
connected to the respirator and the other end to a loudspeaker-
in-box system. This apparatus made it possible to switch the
patient from the respirator to the forced oscillatory setup
during the measurements. These were performed by introdu-
cing pseudorandom pressure excitations generated by the
loudspeaker into the trachea during short (15 s) apneic pauses
introduced into the mechanical ventilation. The forcing signal
consisted of 15-integer multiple components of the 0.4-Hz
fundamental frequency, between 0.4 and 6 Hz. A 28-mm
internal diameter screen pneumotachograph connected to a
differential pressure transducer (ICS model 33NA002D; IC
Sensors, Milpitas, CA) was used to measure tracheal airﬂow.
An identical pressure transducer was used to detect airway
opening pressure. Lung input impedance was computed from
the power spectra of airway opening pressure and tracheal
airﬂow and then ensemble-averaged under each condition. The
mean lung impedance data were ﬁtted using a well-validated
4-parameter model19 containing a frequency-independent air-
way resistance (Raw) and inertance (Iaw) and a constant-phase
tissue compartment characterized by the coefﬁcients of
Table 1
Demographic, Anthropometric, and Clinical Characteristics of the Patients
Group CTRL (n ¼ 91) SEV (n ¼ 99)
Male/female 54/37 53/46
Age, y 65 7 14 63 7 14
Height, cm 167 7 9 168 7 10
Weight, kg 79 7 16 82 7 16
Surgery
AVR/AVP 58 58
AVRþCABG 13 8
MVM/MVP 17 21
Other 11 4
Respiratory comorbidities
Asthma 4 5
Emphysema 9 12
NOTE. Anthropometric data are presented as mean 7 standard deviation.
Abbreviations: AVR/AVP, aortic valve replacement/plasty; CABG, coronary
artery bypass grafting; MVR/MVP, mitral valve replacement/plasty; Other, left
atrial myxoma removal, tricuspid valve plasty, atrial septal defect closure,
ascending aorta aneurysm repair.
Assessed for 
eligibility (n = 300)
Excluded (n = 38)
• Not meeting inclusion 
criteria (n = 28)
• Refused to participate 
(n = 10)
Randomized (n = 262)
Allocated to SEV (n = 131) 
Received allocated 
intervention (n = 101)
Did not receive allocated
intervention:
• Pleural effusion >300 mL (n = 8)
• Administered inotropes (n = 21)
• Asthma exacerbation (n = 1)
Discontinued intervention (n = 0) 
Allocated to CTRL (n = 131) 
Received allocated 
intervention (n = 94)
Did not receive allocated
intervention:
• Pleural effusion >300 mL (n = 10) 
• Administered inotropes (n = 25)
• Asthma exacerbation (n = 2)
Discontinued intervention (n = 0)
Analyzed (n = 91)
Excluded from analysis:
• Measurement artifact
(n = 3)
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Fig 1. CONSORT ﬂow diagram.
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between measured and modeled impedance values were
minimal. Lung tissue hysteresivity was calculated as η ¼ G/H.
Raw represents the ﬂow resistance of the bronchial tree, and
Iaw is related to the mass of the gas in the airways. The tissue
parameters characterize the resistive (G) and elastic properties
of the lung parenchyma (H), and η reﬂects the coupling
between the resistive and elastic properties.
Recording and Analyses of the Expiratory Capnogram
Changes in carbon dioxide (CO2) partial pressure in the
exhaled gas during mechanical ventilation were measured with
a calibrated mainstream capnograph (Capnogard Model 1265,
Novametrix, Andover, MA). The measured signals were
digitized at a sampling frequency of 102.4 Hz and stored on
a computer.
Custom-made software was used to determine the capno-
gram parameters. The phase III slope of the time capnogram
A.L. Balogh et al. / Journal of Cardiothoracic and Vascular Anesthesia 31 (2017) 2017–20262020(SIII) was assessed by ﬁtting a linear regression line to the last
60% of phase III.20–22 Likewise, the phase II slope (SII) was
obtained by ﬁtting a regression line to the points within 20%
of time around the inﬂexion point of phase II.23
Analyses of Blood Gas
The partial pressure of oxygen in the arterial blood (PaO2)
was determined from arterial blood gas samples for the PaO2/
FIO2 ratio and the arterial-to-end-tidal CO2 gradient (Pa-ETCO2).
The intrapulmonary shunt fraction (Qs/Qt) was determined
using the Berggren equation24: Qs/Qt ¼ (CcO2 – CaO2)/
(CcO2 – CvO2), where CcO2, CaO2, and CvO2 are the oxygen
contents of the pulmonary capillary and arterial and central
venous blood, respectively. CcO2 was calculated according to
the alveolar gas equation, assuming the oxygen saturation of
hemoglobin in the pulmonary capillaries to be 100%: CcO2 ¼
1.34 mL/g  Hb þ Sol  (FIO2  713 mmHg – PaCO2/
0.8), where 1.34 mL/g is Hüfner’s constant, Hb is the
hemoglobin concentration in grams, Sol is 0.0031 mL/
100 mL/mmHg, 713 mmHg is the total dry gas pressure,
PaCO2 is the partial pressure of CO2 in the arterial blood, and
0.8 is the respiratory exchange ratio.
Measurement Protocol
The scheme of the experimental protocol is outlined in
Figure 2. When stable hemodynamic and respiratory mechan-
ical conditions had been reached after sternotomy, baseline
measurements were performed 5 minutes before starting CPB.
Measurements included recordings of four 15-second capno-
gram traces; analyses of arterial and central venous blood gas
samples (Radiometer ABL TM 505; Radiometer, Copenhagen,
Denmark); registration of the dynamic respiratory compliance
displayed by the ventilator (C); and collection of 4 lung input
impedance data epochs. The same set of data was gathered
5 minutes after weaning the patient from CPB, when stable
circulatory and ventilator conditions were reestablished. Sub-
sequently, in group SEV, 1 age-related minimal alveolar
concentration (MAC)25 of sevoﬂurane was achieved by settingC
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Fig 2. Timeline for the experimental protocol. Measurements were performed with o
CPB, 5 minutes after weaning from CPB, and after 5 minutes of intervention (a
management [group CTRL]). At each stage, arterial and central venous blood gas sa
was documented, four 15-second capnogram traces were recorded, and 4 impedanthe vaporizer to 1.4% to 1.9% and the fresh gas ﬂow to 16 L/
min, and maintained for 5 minutes with a fresh gas ﬂow of
2 L/min. This interval was chosen based on a previous study,
in which respiratory mechanics were found to reach a steady-
state condition after administering 1 MAC of sevoﬂurane for
5 minutes after the peak effect of an allergen provocation in
rabbits.16 Ventilation was maintained without intervention in
the patients in group CTRL for a matching period. The third
data collection step was taken in the same manner, as detailed
earlier in both groups of patients.Statistical Analyses
Sample size was estimated for a 2-way repeated measures
analysis of variance on H as the primary outcome variable with
an expected effect size of 0.2 (ie, an approximately 20%
change after sevoﬂurane); a power of 0.8; and 2-sided alpha
error of 0.05.26 The estimation resulted in a required sample
size of 97 for each group.
Two-sample t-tests were applied to compare mean age, height,
and weight between the protocol groups. The chi-square test was
used to test the independence of group allocation and sex and the
distribution of surgery types within each group.
Scatters in measured variables are expressed as standard
error of the mean. The normality of the data was tested using
the Kolmogorov-Smirnov test with a Lilliefors correction.
Two-way repeated measures analysis of variance with the
inclusion of an interaction term was used for all measured
variables, with the protocol stage as within-subject factor
(before CPB, after CPB, and after intervention) and group
allocation as between-subject factor (group SEV or group
CTRL) to establish the effects of CPB and the subsequent
administration of sevoﬂurane. The Holm-Sidak multiple com-
parison procedure was adopted to compare the variables in the
study groups at different protocol stages. When comparing
2 samples, the Student t-test was used for normality and the
Mann-Whitney rank sum test otherwise. The statistical tests
were performed with a SigmaPlot statistical software package,
Version 13 (Systat, San Jose, CA). All reported p values are
2-sided.5 min
Sevoflurane
(group SEV, n = 99)
Control
(group CTRL, n = 91)
C
ap
no
gr
am
 x
 4
ZL
 x
 4
C
ap
no
gr
am
 x
 4
ZL
 x
 4
A
B
G
, V
B
G
, C
pen chest condition at the following 3 stages of cardiac surgery: before starting
dministration of sevoﬂurane at 1 MAC [group SEV] or unaltered anesthesia
mples were analyzed, the dynamic lung compliance displayed by the ventilator
ce measurements (ZL) were performed.
Fig 3. Forced oscillatory airway (Raw: airway resistance; Iaw: airway inertance) and tissue (G: tissue damping; H: tissue elastance; η: tissue hysteresivity)
parameters in the group treated with sevoﬂurane at 1 MAC for 5 minutes (SEV) and the control group with intravenous anesthesia maintained (CTRL). Error bars
represent standard error of the mean; *p o 0.05 versus condition “after CPB” within a group; †p o 0.05 versus condition “before CPB” within a group; ‡p o 0.05
between protocol groups within a stage.
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No signiﬁcant difference was found between the protocol
groups in age, height, or weight. The distribution of sex,
surgery types, and respiratory comorbidities was independent
of group allocation (Table 1).
Airway and lung tissue mechanical parameters in both
protocol groups at the different stages of the study protocol
are demonstrated in Figure 3. The CPB-induced changes in
any of the measured parameters in group CTRL were notsigniﬁcantly different from those in group SEV. CPB induced
a signiﬁcant change in all the mechanical parameters, with
the most pronounced elevations in Raw (pooled changes of
287% 7 17%), marked decreases in Iaw (–0.025 7 0.002
cmH2O s2/L), and increases in G (98% 7 27%), whereas
rises in H and η were smaller (15% 7 2.3% and 86% 7
32%, respectively; p o 0.0005 for all). Sevoﬂurane induced
marked drops in Raw (–43% 7 1.9%, p o 0.001); rises in
Iaw (–0.024 7 0.003 cmH2O s2/L); reductions in G
(–23% 7 2.9%, p o 0.001 for all); and moderate decreases
Fig 4. Phase III (SIII) and phase II slopes (SII) of time capnograms, lung compliance (C), PaO2/FIO2 ratio, intrapulmonary shunt fraction (Qs/Qt), and arterial-to-
end-tidal CO2 gradient (Pa-ETCO2) in the group treated with sevoﬂurane at 1 MAC for 5 minutes (SEV) and the control group (CTRL). Error bars represent the
standard error of the mean; *p o 0.05 versus condition “after CPB” within a group; †p o 0.05 versus condition “before CPB” within a group; ‡p o 0.05 between
protocol groups within a stage.
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p o 0.02). There was no evidence of a statistically signiﬁcant
detectable change in any of the parameters in the correspond-
ing time-matched changes in group CTRL.
Capnogram phase slopes, lung compliance, and parameters
associated with oxygenation are demonstrated in Fig 4. The
phase III slope of the capnogram exhibited markedly signiﬁ-
cant increases after CPB in both protocol groups, with
pooled changes of 0.46 7 0.04 mmHg/s (p o 0.0001).
After application of sevoﬂurane, SIII decreased (–0.15 70.036 mmHg/s, p o 0.02), whereas it did not change
signiﬁcantly in group CTRL. No signiﬁcant difference was
found in SII between the protocol groups at any stage (p 4
0.13). The phase II slope decreased markedly after CPB (28%
7 1.5%, p o 0.0001) and increased slightly at the last stage
in both groups (9.8% 7 1.8%, p o 0.02). The changes in the
PaO2/FIO2 ratio, C, Qs/Qt, and Pa-ETCO2 subsequent to CPB
did not differ signiﬁcantly between the protocol groups. The
PaO2/FIO2 ratio and C exhibited signiﬁcant decreases after
CPB (pooled changes of –9.3% 7 2.1% and –13% 7 1.0%,
Fig 5. Association between changes in airway resistance and phase III slope (SIII) after administration of sevoﬂurane at 1 MAC for 5 minutes (group SEV, left) or
IV anesthesia was maintained (group CTRL, right) in each patient. In the left panel, empty symbols represent patients with increasing SIII, whereas ﬁlled symbols
represent patients with decreasing SIII from sevoﬂurane.
A.L. Balogh et al. / Journal of Cardiothoracic and Vascular Anesthesia 31 (2017) 2017–2026 2023respectively), whereas Qs/Qt and Pa-ETCO2 increased (119%
7 9% and 32% 7 9%, respectively; p o 0.0001 for all).
Sevoﬂurane reversed the decreases in the PaO2/FIO2 ratio and
C (15% 7 1.7% and 17% 7 1.4%, respectively; p o 0.0001
for both) and reduced Qs/Qt and Pa-ETCO2 (–20% 7 1.5%
and –9.7% 7 3.3%, respectively; p o 0.03). The corre-
sponding changes in the PaO2/FIO2 ratio, C, and Qs/Qt in
group CTRL were not signiﬁcant.
Figure 5 depicts the associations between the changes in Raw
and SIII after the interventions. Sevoﬂurane decreased Raw in all
but 1 patient, whereas the changes in SIII were far less uniform;Fig 6. Association between post-CPB values of the PaO2/FIO2 ratio (left) and Pa-E
patient; dashed lines denote linear regressions.the administration of sevoﬂurane resulted in further elevations
in SIII in 36 of 99 patients. In contrast, 28 of the 91 patients in
group CTRL exhibited additional elevations in Raw during the
corresponding period, and SIII increased in 35 patients.
The association of post-CPB values of the PaO2/FIO2 ratio
and Pa-ETCO2 and their sevoﬂurane-induced changes are
demonstrated in Figure 6. No statistically signiﬁcant correla-
tion was observed between the PaO2/FIO2 ratio and its change
after sevoﬂurane (R2 ¼ 0.05), whereas a strong negative
correlation was found between Pa-ETCO2 and its change after
sevoﬂurane (R2 ¼ 0.51, p o 0.001).TCO2 (right) and their sevoﬂurane-induced changes. Each symbol represents a
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The results of this study demonstrated the ability of sevo-
ﬂurane to reverse detrimental changes in lung function induced
by extracorporeal circulation in a large cohort of cardiac surgery
patients. Administration of sevoﬂurane uniformly led to marked
airway dilations in almost all the patients, resulting in improved
function of the lung as an oxygenator. Conversely, this
beneﬁcial proﬁle of sevoﬂurane was reﬂected in distinctly
different changes in the capnogram parameter related to
ventilation heterogeneities (SIII). Even though the parameters
presented improved unanimously after the administration of
sevoﬂurane, none of them showed signiﬁcant changes in group
CTRL during the matching period.
Airway and Lung Tissue Mechanics
Sevoﬂurane induced signiﬁcant improvements in the airway
and tissue mechanics compromised by CPB. This ﬁnding was
in accordance with previous results, in which the beneﬁcial
proﬁle of sevoﬂurane was demonstrated against bronchocon-
striction induced by exogenous cholinergic agonists1,2 or after
a release of endogenous mediators.3 Because Raw mainly
reﬂects the ﬂow resistance of the central conducting airways,27
the marked drops in this parameter likely were a reﬂection of
the prominent dilation of proximal airway regions. This idea
was supported by the complete return of Iaw to pre-CPB levels
in group SEV, which may have resulted from the rise of
bronchial volume as a consequence of bronchodilation27 and
from the homogenization of airway calibers.28 The drops in
lung tissue parameters G and H after the administration of
sevoﬂurane may reﬂect an improvement in the parenchymal
viscoelasticity because sevoﬂurane was reported to have
pulmonary anti-inﬂammatory effects.29,30 However, such a
process was not likely to evolve due to the relatively short time
frame (5 min). Another, more probable, mechanism respon-
sible for the improvement in tissue parameters may be due to
alveolar recruitment secondary to bronchodilation and homo-
genization of alveolar ventilation. Accordingly, the drops in G
can be explained by decreasing time constant inequalities
arising from the heterogenous constriction of small airways.
Because sevoﬂurane induced greater drops in G than in H,
their ratio η decreased after the administration of sevoﬂurane,
supporting the notion of lung homogenization.31 The
improved lung aeration from sevoﬂurane also was supported
by the increases in a routinely assessed mechanical parameter
reﬂecting overall lung tissue stiffness (C).
Ventilation and Oxygenation
The phase III slope of the capnogram is determined by the
ventilation and perfusion of the lungs, although the latter process
only accounts for 20% of the change in SIII.32 Furthermore,
the slope of CO2 concentration during alveolar emptying is
governed primarily by Raw.23 Accordingly, an increment in SIII
mainly reﬂects the maldistribution of ventilation, as observed in
asthma,33 in obstructive lung disease,21 or after CPB,23 whereasbronchodilator therapy34 or an optimized ventilation strat-
egy20,22,35 decreases SIII. Considering these earlier ﬁndings, the
decrement in the mean SIII in the study presented here implied
the reduction of ventilation heterogeneity from sevoﬂurane. This
result was in accordance with the beneﬁcial lung mechanical
changes, as previously described.
The lack of difference in the change in SII between the
protocol groups can be explained by the dependence of this
parameter on various lung mechanical properties. In a previous
study, the change in SII exhibited a negative correlation with
the change in Raw and a positive correlation with the change
in C.23 Because sevoﬂurane induced changes in both of these
mechanical parameters, their effects on SII may have been
counterbalanced.
The improvement of ventilation from sevoﬂurane was
manifested in better ventilation-perfusion matching as reﬂected
by the decreased Qs/Qt and a related, more easily accessible
parameter, Pa-ETCO2. Several studies have investigated the
effect of sevoﬂurane on the intrapulmonary shunt fraction, but
they were focused on the potential inhibition of hypoxic
pulmonary vasoconstriction by this volatile agent during
one-lung ventilation. Abe et al reported a decrease in Qs/Qt
after switching from sevoﬂurane to propofol,36 whereas Beck
et al observed similar changes in Qs/Qt among patients
receiving either sevoﬂurane or propofol.37 The discrepancies
in these ﬁndings can be attributed to the dual action of
sevoﬂurane; although it inhibits hypoxic pulmonary vasocon-
striction via vascular smooth muscle relaxation, it also
decreases ventilation-perfusion mismatch by facilitating a
more uniformly distributed ventilation. In the study presented
here, the striking bronchodilation from sevoﬂurane opened
shunted alveolar regions with sustained perfusion in both
lungs. The resultant improvement in ventilation-perfusion
matching most likely outweighed the potential loss of protec-
tive hypoxic pulmonary vasoconstriction, as reﬂected in the
decreased Qs/Qt and Pa-ETCO2. These beneﬁcial changes
ultimately resulted in better oxygenation, as reﬂected by the
increased PaO2/FIO2 ratio. A further noteworthy observation is
that the higher the Pa-ETCO2 after CPB, the greater its
improvement with sevoﬂurane. Even though this relationship
is less apparent for the absolute changes in PaO2/FIO2, this is
of greater importance in patients with low PaO2/FIO2 after
CPB. These ﬁndings indicated the particular beneﬁt of sevo-
ﬂurane in patients with severely compromised gas exchange.
Effect of Sevoﬂurane on Ventilation Heterogeneity
Despite the association between airway caliber and SIII,
23
the magnitude of the decrement in SIII after the administration
of sevoﬂurane did not match that in Raw. Thus, the authors
sought to elucidate the origin of this discrepancy by investi-
gating the association between the changes in Raw and in SIII
after the post-CPB intervention in both protocol groups.
Whereas Raw decreased spontaneously in about two-thirds
of the patients in group CTRL after CPB, bronchodilation was
observed in all the patients but 1 in group SEV. Despite this
uniform change in Raw in the latter group, SIII exhibited
A.L. Balogh et al. / Journal of Cardiothoracic and Vascular Anesthesia 31 (2017) 2017–2026 2025diverse changes, with further elevations in more than one-third
of the patients. This suggested that in these patients, airway
dilation resulted in a more heterogenous alveolar emptying.
Limitations and Future Directions
Because the low-frequency forced oscillation technique
requires general anesthesia and mechanical ventilation, this
study was limited to the assessment of intraoperative changes
in pulmonary mechanics, ventilation, and oxygenation. Sys-
tematic evaluation of the duration of the pulmonary effects of
sevoﬂurane and its possible postoperative beneﬁts (eg, shorter
extubation time and intensive care unit stay, lower frequency
and severity of respiratory morbidities) may be a subject of a
future investigation. Additional research may focus on the
characterization of the preventive potential of sevoﬂurane
administered into the oxygenator during CPB in patients with
airway susceptibilities. Another possible direction for forth-
coming research is the investigation of the potential respiratory
beneﬁt of sevoﬂurane in intensive care unit patients with
respiratory complications, in whom its administration can be
achieved by using the anesthetic-conserving device (Ana-
ConDa; Sendana Medical, Kildare, Ireland).
In conclusion, the results of the present study demonstrated
that bronchoconstriction with subsequent development of
atelectasis and intrapulmonary shunt triggered by CPB can
be alleviated effectively with the application of sevoﬂurane.
This beneﬁt may be of particular importance in patients with
airway hyper-responsiveness, in whom severe bronchocon-
striction is likely to develop after CPB. In such patients,
switching anesthesia management from a total intravenous
approach to an inhalation technique may be recommended.
The potential increase in ventilation heterogeneity after sevo-
ﬂurane may necessitate the elevation of positive end-expira-
tory pressure and/or applying recruitment maneuvers.
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